There has been some encouraging news from the team behind the Oxford University coronavirus vaccine, as their phase two trials show it promotes a strong immune response in older people – the generation most at risk. (Subscribe: They are now…
There has been some encouraging news from the team behind the Oxford University coronavirus vaccine, as their phase two trials show it promotes a strong immune response in older people – the generation most at risk. (Subscribe: They are now…
While Pfizer and BioNTech said a completed analysis of their experimental #Covid-19 vaccine found it protected 95 percent of people against the disease, a new study shows that if you have contracted the virus, you will probably have #immunity for…
Qu Biologics has developed a transformative first-in-class immunotherapy platform, Site Specific Immunomodulators (SSIs), that arms our first line of defense against infectious and non-infectious threats. SSIs are uniquely positioned to be implemented at the time of first emergence of a…